Canada Spends Logo

Explore our Budget 2026 analysis

Grant: CIHR Fellowship

Direct Payment

$150,000.00

Antibody-mediated protection against cell-­associated HIV

FY 2013-14

Summary
Vaccines and therapies for HIV are urgently needed. Broadly neutralizing antibodies against HIV can efficiently stop the spread of HIV in cell culture and protect monkeys from infection with immunodeficiency viruses. It is widely assumed that once we have a vaccine that induces broad and potent neutralizing antibodies, we will have reliable prevention of HIV. There is a major caveat to this scenario. Increasing evidence suggests cell-to-cell transmission of HIV is an important mechanism of initiating and spreading HIV infection. Cell-to-cell spread of HIV will be hidden from neutralizing antibodies that act most efficiently on cell free virus. This could be a major mechanism of evasion from neutralizing antibodies. Other antibody functions, such as antibody-dependent cellular cytotoxicity (ADCC), that can recognize and eliminate infected cells may compensate for this deficit. We will test whether cell-to-cell transmission abrogates the potency of neutralizing antibodies in protecting monkeys from immunodeficiency virus infection. We will define reasons for success or failure that will help with designing and testing better antibody-based strategies to protect against HIV in subsequent human trials.
Program
CIHR Fellowship
Location
Victoria, Australia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
300439
Name
Parsons Matthew S
Region
Victoria
Country
Australia
Orgtype
Research Institution
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
Fellowships - Post-PhD
Projecttitle
Antibody-mediated protection against cell-­associated HIV
Programtype2
Fellowship Programs
Orgnameinp2
Direct Payment
Cihramount2
$150,000
Cihrequipment2
$0
Programname2
CIHR Fellowship
Keyworddelim
Antibody-Dependent Cellular Cytotoxicity; Broadly Neutralizing Antibodies; Cell-Associated Virus; Cell-To-Cell Transmission; Hiv/Aids; Natural Killer Cells; Neutralization; Pigtailed Macaques; Simian-Human Immunodeficiency Virus; Vaccine
Abstract
Vaccines and therapies for HIV are urgently needed. Broadly neutralizing antibodies against HIV can efficiently stop the spread of HIV in cell culture and protect monkeys from infection with immunodeficiency viruses. It is widely assumed that once we have a vaccine that induces broad and potent neutralizing antibodies, we will have reliable prevention of HIV. There is a major caveat to this scenario. Increasing evidence suggests cell-to-cell transmission of HIV is an important mechanism of initiating and spreading HIV infection. Cell-to-cell spread of HIV will be hidden from neutralizing antibodies that act most efficiently on cell free virus. This could be a major mechanism of evasion from neutralizing antibodies. Other antibody functions, such as antibody-dependent cellular cytotoxicity (ADCC), that can recognize and eliminate infected cells may compensate for this deficit. We will test whether cell-to-cell transmission abrogates the potency of neutralizing antibodies in protecting monkeys from immunodeficiency virus infection. We will define reasons for success or failure that will help with designing and testing better antibody-based strategies to protect against HIV in subsequent human trials.
Competitiondate
201311
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Parsons, Matthew S
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $150,000~ $0~
Direct Payment - $150,000 Grant (2013-14) | Canada Spends